Erkut Hasan Borazanci MD MS

PubMed

• A randomized phase II trial of gemcitabine, nab-paclitaxel, cisplatin with or without a medically supervised ketogenic diet for patients with metastatic pancreatic can...
  Gayle S Jameson, Denise J Roe, Erkut Borazanci, Diana L Hanna, Caroline G P Roberts
  Cancer. 2026-03-15
• Phase II Trial of Vemurafenib and Sorafenib Combination in Advanced-Mutated Metastatic Pancreatic Cancer.
  Muhammad Rizwan Khawaja, Gayle Jameson, Derek Cridebring, Patricia Shannon, Haiyong Han
  Journal of Immunotherapy and Precision Oncology. 2026-02-01
• 4 citations
  Validation of a Serum-Based Biomarker Signature for Detection of Early-Stage Pancreatic Ductal Adenocarcinoma.
  Aimee L Lucas, Diane M Simeone, Bryson W Katona, Salvatore Paiella, George Zogopoulos
  Gastroenterology. 2026-02-01

Journal Articles

• Ask ACCC’s Community Resource Centers: Pancreatic adenocarcinoma  
  Borazanci, E, Oncology, 1/1/2014

Abstracts/Posters

• Preliminary activity in the first in human study of the first-in-class fatty acid synthase (FASN) inhibitor, TVB-2640
  Emma Jane Dean, Gerald Steven Falchook, Manish R. Patel, Andrew Jacob Brenner, Jeffrey R. Infante, Hendrik-Tobias Arkenau, Erkut Hasan Borazanci, Juanita Suzanne Lopez..., J Clin Oncol, 1/1/2016
• Phase 1b study of aldoxorubicin + gemcitabine in metastatic solid tumors.
  Kamalesh Kumar Sankhala, Shanta Chawla, Victoria S. Chua, Jasgit C. Sachdev, Erkut Hasan Borazanci, Kelli Sung, Monica M. Mita, Alain C. Mita, Brenda Laabs, Scott Wiel..., J Clin Oncol, 1/1/2016
• First-in-human phase 1 dose-escalation study of DS-6051b, an oral ROS1 and NTRK inhibitor, in subjects with advanced solid tumors.
  Kyriakos P. Papadopoulos, Erkut Borazanci, Daniel Von Hoff, Leena Gandhi, Amita Patnaik, Masaya Tachibana, Hamim Zahir, Roohi Gajee, Terri Goldberg, Giorgio Senaldi, S..., AACR, New Orleans, LA, 1/1/2016

Lectures

• A phase I dose-escalation and immune biomarker study of intravenous FF-10832, liposomal gemcitabine, in patients with advanced solid tumors. 
  2019 ASCO Annual Meeting - 6/1/2019
• A Pilot, Phase II study in patients treated with MM-398, nanoliposomal irinotecan (nal-IRI) using Ferumoxytol (FMX) contrast MRI as a biomarker to predict patient resp... 
  1/1/2014
• Foreign Body Ingestion-presented to LSUHSC-S pediatric students and pediatric staff. 
  Shreveport, LA - 1/1/2007

Other

• Symptoms of Impending Gallbladder Perforation and Acute Cholecystitis in a Pancreatic Cancer Patient Masked by Celiac Plexus Block 
  Borazanci E, Luke Dreisbach L, and Ramanathan RK, Gastroenterology & Hepatology: Open Access
  http://medcraveonline.com/GHOA/GHOA-02-00059.pdf
  1/1/2015
• Multiplatform profiling of rare pancreatic carcinoma subtypes to identify potential actionable targets. 
  Borazanci E, Millis SZ, Winkler J, Ramanathan RK, Von Hoff DD., ASCO Meeting. J Clin Oncol
  1/1/2014
• HonorHealth seeks patients for pancreatic cancer 
  Channel 4TV/CBS5
  http://www.azfamily.com/story/32294178/honorhealth-seeks-patients-for-pancreatic-cancer-study
  1/23/2016